REPLICEL LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0428 USD | +4.99% |
|
-.--% | -4.89% |
| Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
| 2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Performance
| 1 day | +4.99% | ||
| 3 months | -11.39% | ||
| 6 months | -33.44% | ||
| Current year | -4.89% | ||
| 1 year | -54.18% | ||
| 3 years | -85.32% | ||
| 5 years | -82.62% | ||
| 10 years | -99.30% |
Volumes
marketsDaily volume
550
Estimated daily volume
550
Record volume 1
429 181
Record volume 2
382 627
Record volume 3
315 643
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
2 784 341
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
39.48 %
Free-Float capitalization (USD)
1 038 743
Highs and lows
Current year
0.03
0.07
1 year
0.030.19
3 years
0.030.35
5 years
0.030.47
10 years
0.037.36
Indicators
Moving average 5 days
0.04
Moving average 20 days
0.04
Moving average 50 days
0.05
Moving average 100 days
0.05
Price spread / (MMA5)
+1.32%
Price spread / (MMA20)
-7.09%
Price spread / (MMA50)
+5.29%
Price spread / (MMA100)
+16.49%
RSI 9 days
50.91
RSI 14 days
50.12
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.99% | -.--% | -4.89% | -54.18% | 2.78M | ||
| -1.02% | +1.95% | -1.51% | +20.41% | 104B | ||
| -0.09% | +0.59% | +3.22% | +13.74% | 97.42B | ||
| +0.20% | +2.91% | +1.86% | -0.79% | 22.2B | ||
| -0.45% | +1.96% | -16.53% | -24.66% | 21.23B | ||
| -1.79% | -1.74% | -8.49% | -29.67% | 18.33B | ||
| -1.57% | -2.76% | -42.33% | -44.05% | 16.35B | ||
| +3.69% | +9.30% | -20.09% | -44.01% | 15.06B | ||
| -0.80% | +4.31% | +5.47% | +34.19% | 13.98B | ||
| +6.09% | +5.39% | +28.85% | -1.92% | 11.66B | ||
| -4.81% | -7.50% | -24.93% | -33.63% | 8.22B | ||
| -1.14% | +0.71% | +13.68% | +79.49% | 8.18B | ||
| -0.21% | +0.72% | -1.18% | +44.13% | 7.61B | ||
| +0.22% | -2.11% | +249.65% | +205.06% | 7.17B | ||
| -0.62% | -3.17% | -56.69% | -72.31% | 6.86B | ||
| +1.91% | -1.63% | -19.97% | +74.37% | 7B | ||
| Average | +0.29% | +0.94% | +6.63% | +10.39% | ||
| Weighted average by Cap. | -0.28% | +1.21% | +0.74% | +9.99% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -4.81% | ||
| 2023 | -12.45% | ||
| 2022 | -71.65% | ||
| 2021 | +6.58% | ||
| 2020 | -22.58% | ||
| 2019 | -17.03% | ||
| 2018 | -14.58% | ||
| 2017 | -56.34% | ||
| 2016 | -63.21% | ||
| 2015 | -40.43% | ||
| 2014 | -34.55% | ||
| 2013 | +7.61% | ||
| 2012 | -80.43% | ||
| 2011 | +34.29% | ||
| 2010 | +12.90% |
- Stock Market
- Equities
- REPCF Stock
- Quotes RepliCel Life Sciences Inc.
